Categories AlphaGraphs, Earnings, Health Care
ANGO Earnings: Highlights of AngioDynamics’ Q3 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) has reported a wider net loss for the third quarter of 2024 when the medical device maker’s revenue declined. The company also issued guidance for fiscal 2024.
Net loss, excluding special items, was $0.16 per share in the February quarter, compared to a loss of $0.03 per share in the corresponding period of 2023. On an unadjusted basis, net loss was $190.4 million or $4.73 per share in Q3, vs. a loss of $9.5 million or $0.24 per share in the prior-year quarter.
Third-quarter revenues decreased 7% year-over-year to $75.2 million. The company expects fiscal 2024 revenues to be in the range of $270 million to $275 million.
Commenting on the results, AngioDynamics’ CEO Jim Clemmer said, “Subsequent to the end of our fiscal third quarter, we reached a settlement agreement with BD/Bard that provides us with clarity and certainty going forward. This allows us to avoid continued litigation and keep the team focused on further developing our key growth platforms.”
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CAG Earnings: Conagra Brands Q4 adj. profit drops, misses estimates
Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported lower sales and adjusted earnings for the fourth quarter of 2025. Results missed analysts' estimates. Net sales
Delta Air Lines (DAL) Q2 2025 Earnings: Key financials and quarterly highlights
Delta Air Lines (NYSE: DAL) reported its second quarter 2025 earnings results today. Operating revenue remained flat versus the year-ago quarter at $16.64 billion. GAAP net income increased 63% year-over-year
Bank earnings preview: These banking leaders will report Q2 2025 results next week, what to expect
The earnings season is set to kick off next week with quarterly reports from a number of leading banks. JPMorgan Chase & Co. (NYSE: JPM), Citigroup (NYSE: C) and Wells